Clover Health Investments (CLOV) Stock Statistics & Valuation Metrics

Clover Health Investments has a market cap or net worth of $2.56B. The enterprise value is $2.40B.

Market Cap

$2.56B

Enterprise Value

$2.40B

Clover Health Investments has 435,441,350 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

435,441,350

Owned by Insiders

6.79%

Owned by Institutions

22.69%

Clover Health Investments’s return on equity (ROE) is -0.28 and return on invested capital (ROIC) is -25.75%.

Return on Equity (ROE)

-0.28

Return on Assets (ROA)

-0.16

Return on Invested Capital (ROIC)

-25.75%

Return on Capital Employed (ROCE)

-0.26

Revenue Per Employee

2.66M

Profits Per Employee

-118.16K

Employee Count

724

Asset Turnover

3.56

Inventory Turnover

0.00

The current PE Ratio of Clover Health Investments is 283.53. Clover Health Investments’s PEG ratio is 1.34.

PE Ratio

283.53

PS Ratio

0.93

PB Ratio

6.56

Price to FCF

19.35

Price to Operating Cash Flow

18.94

PEG Ratio

1.34

In the last 12 months, Clover Health Investments had revenue of 1.92B and earned -85.55M in profits. Earnings per share was -0.17.

Revenue

1.92B

Gross Profit

355.88M

Operating Income

-85.53M

Pretax Income

-85.55M

Net Income

-85.55M

EBITDA

-83.86M

Earnings Per Share (EPS)

-0.17

In the last 12 months, operating cash flow was 135.31M and capital expenditures -3.03M, giving a free cash flow of 132.28M billion.

Operating Cash Flow

135.31M

Free Cash Flow

132.28M

Free Cash Flow per Share

0.25

Clover Health Investments pays an annual dividend of $0.10, resulting in a dividend yield of ―

Dividend Per Share

$0.10

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

5.17%

Earnings Yield

0.49%

Beta

1.19

52-Week Price Change

84.67%

50-Day Moving Average

4.53

200-Day Moving Average

3.59

Relative Strength Index (RSI)

56.25

Average Volume (3m)

4.22M

Clover Health Investments upcoming earnings date is Mar 04, 2027, TBA (Not Confirmed).

Last Earnings Date

Nov 04, 2026

Next Earnings Date

Mar 04, 2027

Ex-Dividend Date

Aug 23, 2021

Clover Health Investments as a current ratio of 1.47, with Debt / Equity ratio of 0.00%

Current Ratio

1.47

Quick Ratio

1.47

Debt to Market Cap

0.00

Net Debt to EBITDA

0.93

Interest Coverage Ratio

0.00

In the past 12 months, Clover Health Investments has paid 0 in taxes.

Income Tax

0

Effective Tax Rate

0.00

Clover Health Investments EV to EBITDA ratio is 157.44, with an EV/FCF ratio of 17.33.

EV to Sales

0.84

EV to EBITDA

157.44

EV to Free Cash Flow

17.33

EV to Operating Cash Flow

16.94

Clover Health Investments has $272.58M in cash and marketable securities with $0.00 in debt, giving a net cash position of $272.58M billion.

Cash & Marketable Securities

$272.58M

Total Debt

$0.00

Net Cash

$272.58M

Net Cash Per Share

$0.63

Tangible Book Value Per Share

$0.73

Gross margin is 18.86%, with operating margin of 0.45%, and net profit margin of 0.45%.

Gross Margin

18.86%

Operating Margin

0.45%

Pretax Margin

0.45%

Net Profit Margin

0.45%

EBITDA Margin

0.53%

EBIT Margin

0.45%

The average price target for Clover Health Investments is $5.75, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target

$5.75

Price Target Upside

19.29% Upside

Analyst Consensus

Strong Buy

Analyst Count

4

Revenue Growth Forecast

54.46%

EPS Growth Forecast

―

Smart Score

10

AI Score

67